Consensus for risk management in the prescription of biologic therapies or targeted synthetic antirheumatic drugs: Colombian Association of Rheumatology 2023

Elías Gonzalo Forero Illera; Andrés Ricardo Fernández Aldana; Daniel Gerardo Fernández Ávila; Edwin Antonio Jáuregui Cuartas; Gloria Vásquez; Monique Chalem; Wilson Bautista Molano

doi:10.1016/j.rcreu.2024.01.007

Consensus for risk management in the prescription of biologic therapies or targeted synthetic antirheumatic drugs: Colombian Association of Rheumatology 2023

Elías Gonzalo Forero Illera, Andrés Ricardo Fernández Aldana, Daniel Gerardo Fernández Ávila, Edwin Antonio Jáuregui Cuartas, Gloria Vásquez, Monique Chalem, Wilson Bautista Molano

Research output: Contribution to journal › Article › peer-review

Translated title of the contribution	Consenso para la gestión de riesgo en la prescripción de terapias biológicas o de antirreumáticos sintéticos con blanco dirigido: Asociación Colombiana de Reumatología 2023
Original language	English
Pages (from-to)	56-68
Number of pages	13
Journal	Revista Colombiana de Reumatologia
Volume	32
Issue number	1
DOIs	https://doi.org/10.1016/j.rcreu.2024.01.007
State	Published - 01 Jan 2025
Externally published	Yes

Access to Document

10.1016/j.rcreu.2024.01.007

Cite this

Forero Illera, E. G., Fernández Aldana, A. R., Fernández Ávila, D. G., Jáuregui Cuartas, E. A., Vásquez, G., Chalem, M., & Bautista Molano, W. (2025). Consensus for risk management in the prescription of biologic therapies or targeted synthetic antirheumatic drugs: Colombian Association of Rheumatology 2023. Revista Colombiana de Reumatologia, 32(1), 56-68. https://doi.org/10.1016/j.rcreu.2024.01.007

@article{152c71779db5484a8dda50928ac1c99d,

title = "Consensus for risk management in the prescription of biologic therapies or targeted synthetic antirheumatic drugs: Colombian Association of Rheumatology 2023",

author = "{Forero Illera}, {El{\'i}as Gonzalo} and {Fern{\'a}ndez Aldana}, {Andr{\'e}s Ricardo} and {Fern{\'a}ndez {\'A}vila}, {Daniel Gerardo} and {J{\'a}uregui Cuartas}, {Edwin Antonio} and Gloria V{\'a}squez and Monique Chalem and {Bautista Molano}, Wilson",

year = "2025",

month = jan,

day = "1",

doi = "10.1016/j.rcreu.2024.01.007",

language = "English",

volume = "32",

pages = "56--68",

journal = "Revista Colombiana de Reumatologia",

issn = "0121-8123",

publisher = "Asociacion Colombiana de Reumatologia",

number = "1",

}

Forero Illera, EG, Fernández Aldana, AR, Fernández Ávila, DG, Jáuregui Cuartas, EA, Vásquez, G, Chalem, M & Bautista Molano, W 2025, 'Consensus for risk management in the prescription of biologic therapies or targeted synthetic antirheumatic drugs: Colombian Association of Rheumatology 2023', Revista Colombiana de Reumatologia, vol. 32, no. 1, pp. 56-68. https://doi.org/10.1016/j.rcreu.2024.01.007

Consensus for risk management in the prescription of biologic therapies or targeted synthetic antirheumatic drugs: Colombian Association of Rheumatology 2023. / Forero Illera, Elías Gonzalo; Fernández Aldana, Andrés Ricardo; Fernández Ávila, Daniel Gerardo et al.
In: Revista Colombiana de Reumatologia, Vol. 32, No. 1, 01.01.2025, p. 56-68.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Consensus for risk management in the prescription of biologic therapies or targeted synthetic antirheumatic drugs

T2 - Colombian Association of Rheumatology 2023

AU - Forero Illera, Elías Gonzalo

AU - Fernández Aldana, Andrés Ricardo

AU - Fernández Ávila, Daniel Gerardo

AU - Jáuregui Cuartas, Edwin Antonio

AU - Vásquez, Gloria

AU - Chalem, Monique

AU - Bautista Molano, Wilson

PY - 2025/1/1

Y1 - 2025/1/1

UR - http://www.scopus.com/inward/record.url?scp=85190311238&partnerID=8YFLogxK

U2 - 10.1016/j.rcreu.2024.01.007

DO - 10.1016/j.rcreu.2024.01.007

M3 - Article

AN - SCOPUS:85190311238

SN - 0121-8123

VL - 32

SP - 56

EP - 68

JO - Revista Colombiana de Reumatologia

JF - Revista Colombiana de Reumatologia

IS - 1

ER -

Consensus for risk management in the prescription of biologic therapies or targeted synthetic antirheumatic drugs: Colombian Association of Rheumatology 2023

Access to Document

Other files and links

Cite this